A Wednesday night earnings report left big questions about how the spending reductions would affect the company.

Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...

Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results , but sales fell by 10.3% year on year to $165 million.

Roche introduces Sequencing by Expansion (SBX) technology in a webinar just a few days before the AGBT meeting takes place in ...

Arima Genomics expands executive team with three strategic hires to advance clinical applications of 3D genomics.

GeneDx excels in comprehensive genome and exome testing using a vast genetic database linking 400+ diseases. See why I think ...

ProPhase Labs (PRPH) is focused on immediate cash generation through two key initiatives: strategic alternatives including a potential sale of ...